Why Otsuka launched a digital health company

Otsuka America Pharmaceutical is exploring opportunities to treat mental illness in the digital health realm.

Last month, the company launched Otsuka Precision Health (OPH), a data and technology company focused on digital health.

Otsuka tapped longtime executive Sanket Shah to serve as president of OPH and oversee its mission to support Rejoyn, a prescription-only digital therapeutic smartphone app for treating major depressive disorder (MDD).